zoledronic acid has been researched along with Lymph Node Metastasis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caris, C; Cicalese, V; Debruyne, F; Delaere, K; Gomez Veiga, F; Huland, H; Lecouvet, F; Miller, K; Patel, A; Schulze, M; Tammela, T; Tubaro, A; Wirth, M; Witjes, W | 1 |
| Bouvet, M; Hayashi, K; Hiroshima, Y; Hoffman, RM; Kimura, H; Matsumoto, Y; Miwa, S; Sugimoto, N; Tsuchiya, H; Uehara, F; Yamamoto, M; Yamamoto, N; Yano, S; Zhang, Y | 1 |
| Aft, RL; Akazawa, K; Charehbili, A; Coleman, RE; Hasegawa, Y; Hinsley, S; Kohno, N; Kroep, JR; Liefers, GJ; Nortier, JWR; Putter, H; Weilbaecher, K; Winter, MC | 1 |
| Blay, JY; Bompas, E; Bonnet, N; Brisse, H; Brugières, L; Chevance, A; Corradini, N; Entz-Werlé, N; Gentet, JC; Gomez-Brouchet, A; Gouin, F; Guinebretière, JM; Italiano, A; Le Deley, MC; Lervat, C; Marec-Bérard, P; Mascard, E; Pacquement, H; Penel, N; Petit, P; Piperno-Neumann, S; Rédini, F; Tabone, MD | 1 |
| Attard, G; Barber, J; Cassoly, E; Clarke, NW; Cross, W; Dearnaley, DP; Gilson, C; Ibrahim, A; James, ND; Jones, RJ; Logue, J; Lydon, A; Mason, MD; Matheson, D; Millman, R; Nikapota, AD; O'Sullivan, JM; Parker, CC; Parmar, MKB; Porfiri, E; Protheroe, A; Rentsch, CA; Ritchie, AWS; Russell, JM; Schiavone, F; Spears, MR; Srihari, NN; Sydes, MR; Thalmann, GN; Tsang, D; Wagstaff, J; Wallace, J; Walmsley, C | 1 |
| Baldi, A; Caruso, G; Citro, G; Santini, D; Spugnini, EP; Tonini, G; Vincenzi, B | 1 |
| Mukherjee, K; Saha, A; Sonthalia, N; Talukdar, A | 1 |
| Antoniou, N; Bamias, A; Bozas, G; Deliveliotis, C; Dimopoulos, MA; Efstathiou, E; Kastritis, E; Kostakopoulos, A; Papadimitriou, C; Skarlos, D | 1 |
| Inoue, K; Iwase, H; Kawazoe, T; Nagamoto, N; Nakahara, O; Ohsako, T; Sakamoto, N; Yamamoto, Y; Yoshida, Y | 1 |
| Aguilera Tubet, C; Ballestero Diego, R; Roca Edreira, A; Villanueva Peña, A; Zubillaga Guerrero, S | 1 |
1 review(s) available for zoledronic acid and Lymph Node Metastasis
| Article | Year |
|---|---|
Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials.
Topics: Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Female; Humans; Imidazoles; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome; Zoledronic Acid | 2016 |
3 trial(s) available for zoledronic acid and Lymph Node Metastasis
| Article | Year |
|---|---|
Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS).
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Chi-Square Distribution; Diphosphonates; Drug Administration Schedule; Europe; Humans; Imidazoles; Kallikreins; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Grading; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Time Factors; Treatment Failure; Zoledronic Acid | 2015 |
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Case-Control Studies; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Diphosphonates; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Imidazoles; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Osteosarcoma; Prognosis; Survival Rate; Young Adult; Zoledronic Acid | 2016 |
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Celecoxib; Diphosphonates; Disease-Free Survival; Early Termination of Clinical Trials; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Lymphatic Metastasis; Male; Middle Aged; Orchiectomy; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Time Factors; Zoledronic Acid | 2017 |
6 other study(ies) available for zoledronic acid and Lymph Node Metastasis
| Article | Year |
|---|---|
Fluorescence-guided surgery of prostate cancer bone metastasis.
Topics: Adenocarcinoma; Animals; Bone Density Conservation Agents; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Disease-Free Survival; Green Fluorescent Proteins; Humans; Imidazoles; Luminescent Proteins; Lymphatic Metastasis; Male; Mice, Nude; Neoplasm Recurrence, Local; Neoplasm, Residual; Optical Imaging; Prostatic Neoplasms; Red Fluorescent Protein; Zoledronic Acid | 2014 |
Zoledronic acid for the treatment of appendicular osteosarcoma in a dog.
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Dog Diseases; Dogs; Euthanasia, Animal; Forelimb; Imidazoles; Lameness, Animal; Lymph Node Excision; Lymphatic Metastasis; Male; Osteosarcoma; Radiography; Zoledronic Acid | 2009 |
Treatment of hypertrophic osteoarthropathy in the case of pulmonary metastasis secondary-to-nasopharyngeal carcinoma with zoledronic acid: an enlightening experience.
Topics: Adult; Bone Density Conservation Agents; Carcinoma; Diagnosis, Differential; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Osteoarthropathy, Secondary Hypertrophic; Palliative Care; Tomography, X-Ray Computed; Zoledronic Acid | 2012 |
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alopecia; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Disease Progression; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Estramustine; Humans; Imidazoles; Life Tables; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Orchiectomy; Pain; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Taxoids; Treatment Outcome; Zoledronic Acid | 2005 |
[Two cases of stage IV breast cancer with severe hypercalcemia].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Goserelin; Humans; Hypercalcemia; Imidazoles; Leuprolide; Lymph Nodes; Lymphatic Metastasis; Paclitaxel; Quality of Life; Tamoxifen; Zoledronic Acid | 2006 |
[Mediastinal lymph nodes during the course of a metastatic prostate cancer].
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyproterone; Diphosphonates; Estramustine; Fatal Outcome; Flutamide; Humans; Imidazoles; Ketoconazole; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Radionuclide Imaging; Skin Neoplasms; Triptorelin Pamoate; Zoledronic Acid | 2007 |